Attached files

file filename
EX-32.2 - EX-32.2 - Endo International plca20201231ex322cfo906cert.htm
EX-32.1 - EX-32.1 - Endo International plca20201231ex321ceo906cert.htm
EX-31.2 - EX-31.2 - Endo International plca20201231ex312cfo302cert.htm
EX-31.1 - EX-31.1 - Endo International plca20201231ex311ceo302cert.htm
EX-24.1 - EX-24.1 - Endo International plca20201231ex241powerofattor.htm
EX-21.1 - EX-21.1 - Endo International plca20201231ex211subsidiaries.htm
EX-10.35 - EX-10.35 - Endo International plca20201231ex1035malettacont.htm
EX-10.34 - EX-10.34 - Endo International plca20201231ex1034bradleycont.htm
EX-10.33 - EX-10.33 - Endo International plca20201231ex1033barrycontin.htm
EX-10.32 - EX-10.32 - Endo International plca20201231ex1032colemancont.htm
EX-10.24 - EX-10.24 - Endo International plca20201231ex1024coughlinsep.htm
EX-4.1 - EX-4.1 - Endo International plca20201231ex041descriptiono.htm
10-K - 10-K - Endo International plcendp-20201231.htm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-194253, No. 333-204958, No. 333-219806, No. 333-226677, No. 333-233029 and No. 333-241605) and Form S-3 (No. 333-226676) of Endo International plc of our report dated February 26, 2021 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


/S/ PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania
February 26, 2021